Canada markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.29+0.41 (+8.40%)
At close: 04:00PM EST
5.24 -0.05 (-0.95%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close4.88
Open5.06
Bid5.24 x 3000
Ask5.30 x 1800
Day's Range4.91 - 5.46
52 Week Range3.53 - 11.36
Volume18,647,895
Avg. Volume8,440,829
Market Cap628.399M
Beta (5Y Monthly)1.46
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Yahoo Finance Video

    Novavax stock surges after resolving Gavi vaccine dispute

    Vaccine developer Novavax (NVAX) is seeing its stock skyrocket after resolving a dispute with the global nonprofit vaccine alliance Gavi. In an agreement, Novavax has refunded a large portion of Gavi's payment for COVID-19 vaccines that were not delivered. Yahoo Finance Health Reporter Anjalee Khemlani breaks down the details. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Luke Carberry Mogan.

  • Barrons.com

    Novavax Stock Soars 25%. A Vaccine Purchase Settlement Is One Reason Why.

    Novavax was rising sharply Thursday after the vaccine maker reached a settlement with nongovernmental organization Gavi for its Covid-19 vaccine. Novavax said in a news release Thursday that it had reached a settlement related to a 2021 advance purchase agreement for its prototype Covid-19 vaccine. Gavi is an international organization that works to improve access to vaccines for children in lower-income countries.

  • Yahoo Finance Video

    Novavax stock rises on Covid vaccine dispute settlement

    Shares of Novavax (NVAX) are rising after the company moves to settle a dispute over a canceled Covid vaccine purchase agreement. The company will pay up to $475 million over the next 5 years to global vaccine organization, Gavi, The Vaccine Alliance. Yahoo Finance Anchors Rachelle Akuffo and Akiko Fujita break down the latest development for the company and what it means moving forward. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Nicholas Jacobino